CLBAX
Price
$34.75
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
CLBEX
Price
$34.71
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

CLBAX vs CLBEX

Header iconCLBAX vs CLBEX Comparison
Open Charts CLBAX vs CLBEXBanner chart's image
American Funds American Balanced 529A
Price$34.75
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced 529E
Price$34.71
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CLBAX vs CLBEX Comparison Chart
Loading...
VS
CLBAX vs. CLBEX commentary
Sep 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBAX is a StrongBuy and CLBEX is a StrongBuy.

FUNDAMENTALS
Fundamentals
CLBAX (232B) and CLBEX (232B) have equal amount of cash in the bank . CLBAX pays higher dividends than CLBEX: CLBAX (2.23) vs CLBEX (2.02). CLBAX was incepted earlier than CLBEX: CLBAX (23 years) vs CLBEX (23 years). CLBAX (171.00) and CLBEX (171.00) have comparable annual turnover. CLBAX (250) and CLBEX (250) have matching initial minimum investment requirements. CLBAX (19.97) and CLBEX (19.67) have marching annual gain over last year. CLBAX (39.64) and CLBEX (38.00) have equivalent 5 years return.
CLBAXCLBEXCLBAX / CLBEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years23 years-
Gain YTD12.27412.055102%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets232B232B100%
Annual Yield % from dividends2.232.02111%
Returns for 1 year19.9719.67102%
Returns for 3 years12.6211.83107%
Returns for 5 years39.6438.00104%
Returns for 10 years64.4260.61106%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BRDG8.590.65
+8.19%
Bridge Investment Group Holdings
SPRY12.640.64
+5.33%
ARS Pharmaceuticals
AXSM91.750.72
+0.79%
Axsome Therapeutics
ANTX1.04N/A
N/A
AN2 Therapeutics
VEEV219.94-3.96
-1.77%
Veeva Systems